Vulvovaginal Candidiasis (Yeast Infection) Supportive Care Protocol

Vulvovaginal candidiasis (VVC), commonly called a yeast infection, is caused by overgrowth of Candida yeast (usually Candida albicans) in the vagina. It causes vaginal itching, burning, thick white discharge, redness, and pain with sex or urination. About 75% of women experience at least one yeast infection, and some have recurrent infections. Risk factors include antibiotic use, high estrogen states (pregnancy, birth control), diabetes, and immunosuppression.

CRITICAL: Most uncomplicated yeast infections can be treated with over-the-counter antifungal creams/suppositories (miconazole, clotrimazole) or prescription oral fluconazole. See a doctor if this is your first infection, symptoms are severe, you have 4+ infections per year, you're pregnant, or symptoms don't resolve with OTC treatment. Recurrent VVC requires longer treatment courses and possibly maintenance therapy. Symptoms can be similar to other infections (BV, trichomonas, STIs) - get diagnosed if unsure. These supplements may help support treatment and prevent recurrence but shouldn't replace antifungal medication for acute infections.

* Probiotics (Lactobacillus) help restore the healthy vaginal microbiome. A healthy vagina is dominated by Lactobacillus bacteria that produce lactic acid and hydrogen peroxide, creating an acidic environment that inhibits Candida overgrowth. Clinical trials support their use for preventing recurrence.

* Boric Acid (Vaginal) is an effective treatment for recurrent yeast infections and infections caused by non-albicans Candida species (which are often azole-resistant). It acidifies the vaginal environment and has direct antifungal effects.

* Vitamin D deficiency has been associated with recurrent vaginal infections. Adequate levels support mucosal immunity.

* Garlic contains allicin, which has antifungal properties. Oral supplementation is recommended (do NOT insert garlic vaginally).

* Tea Tree Oil has antifungal properties. Commercial vaginal products containing tea tree oil are available; do not apply undiluted essential oil.

* Oregano Oil and Caprylic Acid have antifungal activity in laboratory studies.

Expected timeline: Antifungal medication: symptoms usually improve within 3 days, complete resolution in 7-14 days. Probiotics for prevention: ongoing use. Boric acid: typically 14-day course for recurrent VVC.

Clinical Perspective

Vulvovaginal candidiasis (VVC): vaginal infection caused by Candida species, usually C. albicans (~90%), also C. glabrata, C. tropicalis, C. parapsilosis. Classification: uncomplicated (mild-moderate, sporadic, C. albicans, immunocompetent) vs complicated (severe, recurrent ≥4/year, non-albicans, immunocompromised, pregnancy). Symptoms: pruritus, burning, dyspareunia, dysuria, thick white discharge. Diagnosis: pH <4.5 (vs BV), KOH prep (pseudohyphae/yeast), culture if recurrent/treatment failure.

CRITICAL: Uncomplicated VVC: topical azoles (miconazole, clotrimazole) x 1-7 days OR oral fluconazole 150mg single dose. Complicated/recurrent VVC: longer treatment (fluconazole 150mg days 1, 4, 7, then weekly x 6 months), boric acid for resistant species. Non-albicans Candida: often azole-resistant; boric acid first-line. Pregnancy: topical azoles only (7-day course); avoid fluconazole. Rule out other vaginitis (BV, trichomonas). Supplements are ADJUNCTIVE for prevention.

* Probiotics (B-grade): Lactobacillus restoration. Cochrane review: adjunctive benefit (PMID: 25215552). Meta-analysis: reduced recurrence (PMID: 30467329). L. rhamnosus GR-1, L. reuteri RC-14. 10-20 billion CFU daily.

* Boric Acid (B-grade): Acidifies vagina; antifungal. Systematic review: effective for recurrent VVC (PMID: 25855664). 600mg vaginal suppository x 14 days. First-line for non-albicans.

* Vitamin D (C-grade): Immune support. Systematic review: deficiency and vaginal infections (PMID: 26398196). 2000-4000 IU daily.

* Garlic (C-grade): Allicin antifungal. Review: in vitro activity (PMID: 26192919). 600-1200mg aged garlic daily. Do NOT use vaginally.

* Tea Tree Oil (C-grade): Antifungal. In vitro study: Candida activity (PMID: 16418522). Commercial vaginal products; avoid undiluted.

* Oregano Oil (C-grade): Carvacrol/thymol antifungal. In vitro study (PMID: 11855702). 200-600mg capsules daily.

* Caprylic Acid (C-grade): MCFA antifungal. In vitro study (PMID: 17651080). 500-2000mg daily.

Biomarker targets: Symptom resolution, negative KOH prep/culture, recurrence prevention.

Protocol notes: Risk factor modification: limit unnecessary antibiotics, control diabetes, loose cotton underwear, avoid douching and scented products. Recurrent VVC definition: ≥4 episodes/year. Recurrent VVC workup: culture (species identification), glucose/HbA1c, HIV if risk factors. Maintenance therapy: weekly fluconazole or boric acid 2x/week. Treatment during menses may be less effective. Partner treatment not routinely needed (yeast not STI). Pregnancy: avoid fluconazole (teratogenic); 7-day topical azoles. Probiotic strains: L. rhamnosus GR-1 and L. reuteri RC-14 best studied for vaginal health. Vaginal application of probiotics also possible. Diet: controversial; some recommend reducing sugar/refined carbs. Boric acid: not for oral use, not during pregnancy. Tea tree: can be irritating - use commercial products, not pure oil. If not responding: consider resistant species, incorrect diagnosis, compliance issues.

View All Protocols